title: [Immediate and long-term outcomes after "Ephesos" coronary stent implantation in patients with stable or unstable angina].
abstract: OBJECTIVE
  An open non-randomized trial was initiated to assess clinical and angiographic results of using the coronary stent "Ephesos" in 457 patients with stable or unstable angina pectoris and native coronary affections.
  
  
  METHODS
  268 stents have been implanted in 231 patients with stable angina (SA) and 271 stents--in 226 patients with unstable angina (UA). 46% lesions were complicated. The length of stenosis was 12.9 +/- 6.7 mm in the group SA and 14.1 +/- 7.4 mm in the group UA, 30% stenoses were long.
  
  
  RESULTS
  Successful stenting was stated in 99% without cases of acute thrombosis. Non-fatal myocardial infarction took place in hospital in 1.3% of SA patients and in 2.6% of UA patients. Incidence of cardiac complications (death, recurrent angina pectoris, myocardial infarction, restenosis, repeated revascularization) for 6-month follow-up was 15.6% in SA group and 18.1% in UA group. At angiographic control, the index of vascular diameter loss made up 0.22 +/- 0.2 in SA group and 0.3 +/- 0.27 in UA group. Incidence of restenosis was 12 and 14%, respectively. 18-month follow-up found no differences in frequency of complications: 21.6 and 22.6% in groups SA and UA, respectively.
  
  
  CONCLUSIONS
  Implantation of the stent "Ephesos" is effective in prevention of thrombosis and restenosis in patients with stable or unstable angina pectoris at high risk of intervention.
authors.forename: A N
authors.initials: AN
authors.lastname: Samko
authors.forename: I V
authors.initials: IV
authors.lastname: Pershukov
authors.forename: T A
authors.initials: TA
authors.lastname: Batyraliev
authors.forename: Z A
authors.initials: ZA
authors.lastname: Niiazova-Karben
authors.forename: O
authors.initials: O
authors.lastname: Kalenich
authors.forename: A
authors.initials: A
authors.lastname: Karaus
authors.forename: N
authors.initials: N
authors.lastname: Giuler
authors.forename: B
authors.initials: B
authors.lastname: Erenuchu
authors.forename: S
authors.initials: S
authors.lastname: Kadayĭfchi
authors.forename: A
authors.initials: A
authors.lastname: Temamogullari
authors.forename: S
authors.initials: S
authors.lastname: Ozgul'
authors.forename: F
authors.initials: F
authors.lastname: Akgul'
authors.forename: I V
authors.initials: IV
authors.lastname: Levitskiĭ
authors.forename: A V
authors.initials: AV
authors.lastname: Sozytkin
authors.forename: F
authors.initials: F
authors.lastname: Besnili
authors.forename: F
authors.initials: F
authors.lastname: Arful'
authors.forename: Sh T
authors.initials: ShT
authors.lastname: Zhamgyrchiev
authors.forename: A
authors.initials: A
authors.lastname: Serchelik
authors.forename: Kh
authors.initials: Kh
authors.lastname: Shengul
authors.forename: B S
authors.initials: BS
authors.lastname: Daniiarov
authors.forename: O
authors.initials: O
authors.lastname: Demirbash
authors.forename: Iu N
authors.initials: IuN
authors.lastname: Belenkov
mesh_terms: D000787:Angina Pectoris / Q000601:surgery*; D023921:Coronary Stenosis / Q000517:prevention & control; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D015607:Stents / Q000009:adverse effects; D013927:Thrombosis / Q000517:prevention & control; D016896:Treatment Outcome